RestorOx™, formulated with Accelerated Hydrogen Peroxide®, is approved for use against some of the world’s most dangerous pathogens under the EPA emerging viral pathogen guidance, including SARS-CoV-2, the virus that causes COVID-19.
In cases of emerging viral pathogens like SARS-CoV-2, the virus that causes COVID-19, when there is no test that can be conducted to validate the efficacy of a disinfectant, the EPA utilizes Emerging Viral Pathogen Guidance to determine the expected efficacy of a disinfectant against an emerging virus. This guidance, used previously during the 2003 SARS epidemic, mandates that for disinfectant products to be approved, they must be an EPA registered Hospital or Broad-Spectrum disinfectant and have proven efficacy against two small, non-enveloped viruses, such as Poliovirus and Parvovirus.
Knowing that emerging viral pathogens are an increasing public health concern, all RestorOx™ products are designed to meet each of the three levels defined in the EPA’s emerging viral pathogen guidance. In choosing RestorOx™ as your daily disinfectant we want to ensure you have the confidence that you are covered in the event of any emerging viral pathogen outbreak.
The Technology That Powers RestorOx™
We welcome you to take a look at the process behind the technology that powers RestorOx™. As presented by The Wall Street Journal
Virox Technologies Inc. AHP formula is the cutting edge technology behind RestorOx™. To get us where we are today, AHP has been trusted and accepted in a multitude of industries, just to name a few; hospitals, cruise ships, animal health and dentistry.
Ask Us a Question
If you would like to learn more about RestorOx™, please contact us by completing the form below.